The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival.Vise andre og tillknytning
2004 (engelsk)Inngår i: BMC Cancer, ISSN 1471-2407, Vol. 4, nr 1, s. 66-Artikkel i tidsskrift (Fagfellevurdert) Published
sted, utgiver, år, opplag, sider
2004. Vol. 4, nr 1, s. 66-
Emneord [en]
Adenocarcinoma/immunology, Antibodies/*blood, Carcinoma; Non-Small-Cell Lung/*immunology/mortality/pathology, Carcinoma; Squamous Cell/immunology, Disease Progression, Female, Humans, Lung Neoplasms/*immunology/mortality/pathology, Male, Neoplasm Staging, Protein p53/*immunology, Research Support; Non-U.S. Gov't, Survival Analysis, Survival Rate
Identifikatorer
URN: urn:nbn:se:uu:diva-69918PubMedID: 15367333OAI: oai:DiVA.org:uu-69918DiVA, id: diva2:97829
2005-05-272005-05-272011-01-12